Jennifer Wu Shadow Health Guide — Gestational Diabetes Assessment & What to Document

Jennifer Wu is a 41-year-old patient at 27 weeks gestation who was diagnosed with gestational diabetes after a failed glucose tolerance test. The case is practical because it tests a common maternity scenario: a patient who may not feel obviously ill, but still needs careful assessment, teaching, and follow-up planning.

If you are reviewing this encounter, it helps to focus on how prenatal assessment, glucose findings, nutrition teaching, maternal risk, and fetal well-being fit together in one organized nursing response.

The Jennifer Wu case is not just about repeating the diagnosis. It tests whether the student can link prenatal context, glucose findings, diet and lifestyle education, maternal risk, and fetal monitoring awareness into one organized nursing encounter.

Because gestational diabetes can seem straightforward on paper, students sometimes under-document it. The better submissions show why screening follow-up matters, what questions belong in the focused history, and how education should sound when you are explaining glucose monitoring, nutrition, and pregnancy safety to the patient.

Students usually weaken this case when they rush through teaching or fail to make the assessment feel pregnancy-specific. A strong note does more than say “teach about blood sugar.” It explains why glucose control matters at 27 weeks, what the patient should be watching for, and what follow-up needs to happen next.

Another common issue is treating the case like a generic diabetes visit. Jennifer Wu is a maternity patient first, so fetal well-being, prenatal progress, and pregnancy-related counseling need to stay visible throughout the encounter.

Jennifer Wu connects naturally to other maternity-focused patients like Gloria Hernandez, Naomi Adebayo, Luna Morales, and Daanis LaFontaine. Reviewing them together helps students see how prenatal assessment priorities shift from one scenario to another.

That broader review approach is useful because some maternity cases are remembered by patient name while others are approached through the condition itself. Looking at both angles can make your notes, priorities, and patient teaching feel more complete.

Gestational diabetes mellitus (GDM) is diagnosed when the body cannot produce enough insulin to meet the increased demands of pregnancy. The standard screening window is 24 to 28 weeks, starting with a 1-hour glucose challenge test. A failed result — typically a glucose level above 130 to 140 mg/dL — is followed by a 3-hour oral glucose tolerance test to confirm the diagnosis. Jennifer Wu has already crossed that diagnostic threshold.

What makes the 27-week timing clinically significant is that this is a period of rapid fetal growth. Elevated maternal glucose crosses the placenta, causing the fetus to produce excess insulin in response, which drives accelerated growth. Understanding this mechanism gives the student a clear reason for everything that follows in the encounter: the dietary targets, the monitoring schedule, the fetal surveillance, and the patient education.

Unlike pre-existing Type 2 diabetes, GDM typically resolves after delivery — but it significantly raises the patient's lifetime risk of developing Type 2 diabetes, which matters for long-term counseling. In a Shadow Health virtual patient encounter, demonstrating this distinction is one of the things that signals real clinical reasoning rather than surface-level documentation.

The focused history is where submissions often gain or lose the most ground. For this case, the following questions are clinically appropriate and are likely to be rewarded by the simulation platform:

• Dietary history — What does a typical day of eating look like? How often are meals? Are there frequent carbohydrate-heavy choices, skipped meals, or late-night snacking?
• Physical activity — What type of exercise, how often, and for how long? Activity level at 27 weeks is directly relevant to glucose management.
• Prior pregnancy history — Has she had gestational diabetes in a previous pregnancy? Any history of delivering a large-for-gestational-age or macrosomic baby?
• Family history of diabetes — First-degree relatives with Type 2 diabetes raises long-term risk and reinforces why postpartum follow-up matters.
• Current symptoms — Excessive thirst, urination beyond normal pregnancy frequency, unusual fatigue, or any episodes of shakiness that could suggest glycemic instability.
• Fetal movement — Is she feeling consistent movement? Fetal kick counts are an appropriate topic to introduce at 27 weeks, and the simulation may reward documenting it here.

The goal is not to cover every possible question but to ask the ones that connect directly to gestational diabetes, pregnancy safety, and the patient's current experience.

Patient education is one of the most heavily weighted components in the Jennifer Wu simulation. Vague instructions — "watch your diet" or "check your blood sugar" — will not score well. Teaching needs to be specific, pregnancy-contextualized, and grounded in clinical targets.

Blood glucose targets during pregnancy: Fasting glucose should remain below 95 mg/dL. One hour after meals, the target is below 140 mg/dL. Two hours after meals, below 120 mg/dL. These are tighter than standard diabetes thresholds because elevated glucose crosses the placenta directly.

Meal structure: Rather than three large meals, the recommendation is three moderate meals plus two to three small snacks per day. This distributes carbohydrate intake across the day and prevents the glucose spikes that follow large meals. High-fiber foods, lean proteins, and lower-glycemic choices help maintain steadier levels. A bedtime snack that includes protein is often recommended to manage fasting glucose overnight.

Exercise: Walking 20 to 30 minutes after meals is one of the most practical ways to lower postprandial glucose. At 27 weeks, low-impact activity is appropriate and should be encouraged unless a contraindication exists.

Signs of hypoglycemia: Shakiness, sweating, rapid heartbeat, lightheadedness, and confusion. The patient should know how to treat mild episodes with a fast-acting carbohydrate — orange juice or glucose tablets — and understand when to call the provider rather than self-treat.

When to call: Fasting glucose consistently above 95 mg/dL, inability to manage dietary changes, symptoms of hypoglycemia, or any decrease in fetal movement.

A complete submission addresses both the maternal and fetal sides of the encounter. Students who document only the mother's risk are missing half of what makes GDM clinically significant at this stage. The following points belong in the assessment:

• Macrosomia — Excess maternal glucose drives fetal hyperinsulinemia, which accelerates fetal growth beyond normal limits. A large-for-gestational-age baby increases the risk of birth complications including shoulder dystocia and cesarean delivery.
• Neonatal hypoglycemia — After delivery, the newborn loses access to the high-glucose maternal environment but still has elevated insulin production. Blood glucose monitoring in the newborn period is standard practice for infants of diabetic mothers.
• Increased fetal surveillance — Jennifer Wu may require non-stress tests (NST) or biophysical profiles in the third trimester to assess fetal well-being. Demonstrating awareness of this monitoring pathway is appropriate even at 27 weeks.
• Polyhydramnios — Excess amniotic fluid associated with poorly controlled GDM can increase the risk of preterm labor. This is a relevant complication to acknowledge in the plan section, even if it is not the primary focus of the current visit.

Including these points shows that the student understands gestational diabetes as a condition that affects the entire pregnancy, not just the mother's glucose level.

Many submissions end with the assessment findings and omit a clear plan. A structured plan section is part of what separates a strong note from an average one. For Jennifer Wu at 27 weeks, the plan should address:

• Glucose monitoring schedule — Fasting glucose daily and one-hour post-meal readings after each main meal. Values should be logged and reviewed at each prenatal visit. Target thresholds should be stated explicitly in the note, not left general.
• Dietitian referral — Medical nutrition therapy is the first-line management for GDM. A referral to a registered dietitian with prenatal experience should be documented rather than left implied.
• Escalation threshold — When dietary changes alone are not controlling glucose, insulin is the preferred pharmacological option in pregnancy because it does not cross the placenta. Noting when and why insulin would be initiated shows clinical foresight even when medication is not started in this encounter.
• Postpartum follow-up — After delivery, the patient should be retested for Type 2 diabetes at 6 to 12 weeks postpartum and then every 1 to 3 years. Including this in the teaching reinforces that the conversation extends beyond the current pregnancy.

Jennifer Wu is 41 years old and managing a new diagnosis at 27 weeks. The psychosocial piece of this encounter is easy to overlook when the focus narrows entirely to glucose numbers and dietary targets, but it is part of what a complete holistic nursing note includes.

Relevant questions: How is she responding emotionally to the diagnosis? Does she have concerns about what it means for her baby? Does she have support at home for managing dietary changes? Are there practical or cultural barriers to following the monitoring schedule or meal plan?

Anxiety about fetal outcomes is common and worth addressing directly. Reassuring the patient that well-managed GDM typically results in healthy outcomes — while being clear about the importance of consistent monitoring — is part of the therapeutic encounter, not a detour from the clinical work.

This same approach to holding both the clinical and emotional dimensions together applies across the other maternity Shadow Health assessments on the platform. Cases like Naomi Adebayo and Daanis LaFontaine also require the student to stay grounded in the patient's experience while managing a complex clinical picture.

The Jennifer Wu case centres on gestational diabetes education and documentation — not just screening results. Students who score highest are those who document the patient's understanding of dietary modifications, blood glucose monitoring, and follow-up care as clearly as they document the clinical findings themselves.

According to the American Diabetes Association, gestational diabetes affects approximately 2–10% of pregnancies in the United States annually, and evidence-based prenatal education at the point of diagnosis significantly reduces the risk of both maternal and neonatal complications.

The most common scoring gap in this case is thin prenatal education documentation. Noting that you 'discussed diet' is not sufficient — examiners look for specific teaching points, patient verbalisations of understanding, and a documented follow-up plan tied directly to the glucose result.